Skip to content
zameds
Loading the molecular structure
C22H28N2O336.50 g/mol

N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 3345.

Registration

Applicants
1
Registrations
4

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Sandoz South Africa (Pty) LtdFendermal /h25 ug, 50 ug, 75 ug, 100 ug440757, 440758, 440759, 440760Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Fendermal 25 ug/h

EACH PATCH DELIVERS FENTANYL 25,0 ug

25 ug44075744/2.9/0757RegisteredNot determinedNone
Fendermal 50 ug/h

EACH PATCH DELIVERS FENTANYL 50,0 ug

50 ug44075844/2.9/0758RegisteredNot determinedNone
Fendermal 75 ug/h

EACH PATCH DELIVERS FENTANYL 75,0 ug

75 ug44075944/2.9/0759RegisteredNot determinedNone
Fendermal 100 ug/h

EACH PATCH DELIVERS FENTANYL 100,0 ug

100 ug44076044/2.9/0760RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S6: Fentanyl

    • when intended for therapeutic purposes.

    Consolidated Schedules 06 July 2026, line 10256

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading...
Loading Wikipedia summary

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles